CELGENE CORP /DE/ 4
4 · CELGENE CORP /DE/ · Filed May 15, 2015
Insider Transaction Report
Form 4
STEIN LAWRENCE V
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2015-05-14$39.33/sh+2,542$99,977→ 16,591 total - Sale
Common Stock
2015-05-14$114.85/sh−2,542$291,949→ 14,049 total - Exercise/Conversion
Stock Option (right to buy)
2015-05-14−2,542→ 5,084 totalExercise: $39.33Exp: 2022-12-03→ Common Stock (2,542 underlying)
Holdings
- 519(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]The option was fully exercisable.
- [F2]The option was issued pursuant to the Celgene Corporation 2008 Stock Incentive Plan (amended and restated as of April 17, 2013).